LA Leiter

715 total citations
18 papers, 517 citations indexed

About

LA Leiter is a scholar working on Surgery, Pharmacology and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, LA Leiter has authored 18 papers receiving a total of 517 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Surgery, 4 papers in Pharmacology and 4 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in LA Leiter's work include Nutritional Studies and Diet (4 papers), Blood Pressure and Hypertension Studies (4 papers) and Sodium Intake and Health (3 papers). LA Leiter is often cited by papers focused on Nutritional Studies and Diet (4 papers), Blood Pressure and Hypertension Studies (4 papers) and Sodium Intake and Health (3 papers). LA Leiter collaborates with scholars based in Canada, United States and United Kingdom. LA Leiter's co-authors include Arun Chockalingam, N R Campbell, J. David Spence, G. Harvey Anderson, James O. Hill, Zhe Li, Kellie E. Murphy, R. Paul Aftring, Peter Jacobson and Jens Jordan and has published in prestigious journals such as The Journal of Clinical Endocrinology & Metabolism, Annals of the New York Academy of Sciences and European Heart Journal.

In The Last Decade

LA Leiter

18 papers receiving 486 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
LA Leiter Canada 13 181 152 94 90 81 18 517
Marco Versiero Italy 8 200 1.1× 277 1.8× 62 0.7× 175 1.9× 109 1.3× 12 656
R LEWANCZUK Canada 15 241 1.3× 247 1.6× 94 1.0× 117 1.3× 78 1.0× 19 614
Georgia Argyrakopoulou Greece 13 150 0.8× 196 1.3× 198 2.1× 141 1.6× 48 0.6× 31 782
Robert Hogikyan United States 16 96 0.5× 390 2.6× 90 1.0× 102 1.1× 45 0.6× 38 752
D. Gordon United Kingdom 13 190 1.0× 182 1.2× 55 0.6× 68 0.8× 86 1.1× 24 614
Haskel Eliahou Israel 9 165 0.9× 228 1.5× 158 1.7× 113 1.3× 114 1.4× 15 795
Thomas Makris Greece 19 148 0.8× 390 2.6× 64 0.7× 102 1.1× 57 0.7× 41 813
William H. Frishman United States 16 122 0.7× 419 2.8× 41 0.4× 160 1.8× 33 0.4× 71 774
Judith E. Soberman United States 15 117 0.6× 243 1.6× 32 0.3× 73 0.8× 34 0.4× 37 609
Ove K. Andersson Sweden 18 252 1.4× 570 3.8× 92 1.0× 87 1.0× 103 1.3× 56 890

Countries citing papers authored by LA Leiter

Since Specialization
Citations

This map shows the geographic impact of LA Leiter's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by LA Leiter with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites LA Leiter more than expected).

Fields of papers citing papers by LA Leiter

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by LA Leiter. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by LA Leiter. The network helps show where LA Leiter may publish in the future.

Co-authorship network of co-authors of LA Leiter

This figure shows the co-authorship network connecting the top 25 collaborators of LA Leiter. A scholar is included among the top collaborators of LA Leiter based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with LA Leiter. LA Leiter is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
2.
Landmesser, Ulf, Arash Haghikia, LA Leiter, et al.. (2020). Effect of inclisiran, the siRNA against PCSK9, on platelets, immune cells and immunological biomarkers - a pre-specified analysis from ORION-1.. Cardiovascular Research. 16 indexed citations
3.
Wright, R. Scott, Frederick J. Raal, David Kallend, et al.. (2020). Inter-individual variability in LDL-C reductions with inclisiran – data from ORION-10 and ORION-11. European Heart Journal. 41(Supplement_2). 4 indexed citations
4.
Raz, Itamar, Ofri Mosenzon, Avivit Cahn, et al.. (2018). Ausgangscharakteristika der DECLARE-TIMI-58-Studienpopulation. Diabetologie und Stoffwechsel. 4 indexed citations
5.
Leiter, LA, et al.. (2016). Gastrointestinal safety across the albiglutide development programme. Diabetes Obesity and Metabolism. 18(9). 930–935. 12 indexed citations
6.
Aroda, Vanita R., Timothy S. Bailey, Bertrand Cariou, et al.. (2016). Effect of adding insulin degludec to treatment in patients with type 2 diabetes inadequately controlled with metformin and liraglutide: a double‐blind randomized controlled trial ( BEGIN : ADD TO GLP ‐1 S tudy). Diabetes Obesity and Metabolism. 18(7). 663–670. 21 indexed citations
7.
Jordan, Jens, LA Leiter, Zhe Li, et al.. (2007). Stimulation of Cholecystokinin-A Receptors With GI181771X does not Cause Weight Loss in Overweight or Obese Patients. Clinical Pharmacology & Therapeutics. 83(2). 281–287. 87 indexed citations
8.
Leiter, LA. (2005). β‐cell preservation: a potential role for thiazolidinediones to improve clinical care in Type 2 diabetes. Diabetic Medicine. 22(8). 963–972. 33 indexed citations
9.
10.
Campbell, N R, Ellen Burgess, Elinor Wilson, et al.. (1999). Lifestyle changes to prevent and control hypertension: do they work? A summary of the Canadian consensus conference.. PubMed. 160(9). 1341–3. 18 indexed citations
11.
Campbell, Norm R.C., Ellen Burgess, Elinor Wilson, et al.. (1999). Lifestyle modifications to prevent and control hypertension. 1. Methods and an overview of the Canadian recommendations. Canadian Hypertension Society, Canadian Coalition for High Blood Pressure Prevention and Control, Laboratory Centre for Disease Control at Health Canada, Heart and Stroke Foundation of Canada.. PubMed. 160(9 Suppl). S1–6. 35 indexed citations
12.
Feldman, Ross D., Norman R.C. Campbell, Pierre Larochelle, et al.. (1999). 1999 Canadian recommendations for the management of hypertension. Task Force for the Development of the 1999 Canadian Recommendations for the Management of Hypertension.. PubMed. 161 Suppl 12. S1–17. 79 indexed citations
13.
Leiter, LA, et al.. (1999). Lifestyle modifications to prevent and control hypertension. 2. Recommendations on obesity and weight loss. Canadian Hypertension Society, Canadian Coalition for High Blood Pressure Prevention and Control, Laboratory Centre for Disease Control at Health Canada, Heart and Stroke Foundation of Canada.. PubMed. 160(9 Suppl). S13–12. 85 indexed citations
14.
Leiter, LA, et al.. (1999). Evaluation of 8 mm insulin pen needles in people with type 1 and type 2 diabetes. Practical Diabetes International. 16(5). 145–148. 20 indexed citations
15.
Chockalingam, Arun, Martin J. Bass, Rebecca A. Battista, et al.. (1990). Recommendations of the Canadian Consensus Conference on Non-Pharmacological Approaches to the Management of High Blood Pressure, Mar. 21-23, 1989, Halifax, Nova Scotia.. PubMed. 142(12). 1397–409. 28 indexed citations
16.
Anderson, G. Harvey & LA Leiter. (1988). Effects of aspartame and phenylalanine on meal-time food intake of humans. Appetite. 11. 48–53. 14 indexed citations
17.
Leiter, LA, Nina Hrboticky, & G. Harvey Anderson. (1987). Effects of l‐Tryptophan on Food Intake and Selection in Lean Men and Women. Annals of the New York Academy of Sciences. 499(1). 327–328. 9 indexed citations
18.
Stone, Edwin M., LA Leiter, John Lambert, et al.. (1984). L-Thyroxine Absorption in Patients with Short Bowel. The Journal of Clinical Endocrinology & Metabolism. 59(1). 139–141. 50 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Marco Versiero Breakdown of academic impact, for papers by R LEWANCZUK Breakdown of academic impact, for papers by Georgia Argyrakopoulou Breakdown of academic impact, for papers by Robert Hogikyan Breakdown of academic impact, for papers by D. Gordon Breakdown of academic impact, for papers by Haskel Eliahou Breakdown of academic impact, for papers by Thomas Makris Breakdown of academic impact, for papers by William H. Frishman Breakdown of academic impact, for papers by Judith E. Soberman Breakdown of academic impact, for papers by Ove K. Andersson
Rankless by CCL
2026